Skip to main content
SpringerLink
Log in

Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid

  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

Tranexamic acid as an antifibrinolytic agent has been investigated in a controlled study in patients with recent subarachnoid haemorrhage. It is concluded that tranexamic acid improves neither rebleeding rates, nor mortality. Predominantly thrombotic complications have been noted as a more serious side effect of tranexamic acid.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alkjaerig, N., Fletcher, A. P., Sherry, S., E-aminocaproic acid: an inhibitor of plasminogen activation. J. Biol. Chem.234 (1959), 832–837.

    PubMed  Google Scholar 

  • Andersson, L., Nilsson, J. M., AMCA, a patent haemostatic agent in urinary tract bleeding. Scand. J. Urol. Nephrol.3 (1969), 169–176.

    PubMed  Google Scholar 

  • — —, Colleen, S., Grandstrand, B., Melander, B., Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA. Ann. N.Y. Acad. Sci.146 (1968), 642–658.

    PubMed  Google Scholar 

  • Botterell, E. H., Lougheed, W. M., Scott, J. W., Vanderwater, S. L., Hypothermia and interruption of carotid, or carotid and vertebral circulation in the surgical management of intracranial aneurysms. J. Neurosurg.13 (1956), 1–42.

    PubMed  Google Scholar 

  • Charyton, C., Purtilo, D., Glomerulas capillary thrombosis and acute renal failure after epsilon-aminicaproic acid therapy. N. Engl. J. Med.279 (1969), 1102–1104.

    Google Scholar 

  • Claus, A., Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta haemat. (Basel)17 (1957), 237–246.

    Google Scholar 

  • Gorkill, Br., Earlier operation and anti-fibrinolytic therapy in the management of aneurysmal subarachnoid hemorrhage: review of recent experience in Tasmania. Med. J. Aust.1 (1974), 468–470.

    PubMed  Google Scholar 

  • Gralnick, H. R., Greipp, P., Thrombosis with epsilon-amino-caproic acid therapy. Amer. J. Clin. Pathol.56 (1971), 151–154.

    Google Scholar 

  • Locksley, H. B., Report on the cooperative study of intracranial aneurysms and subarachnoid hemorrhage. Section V, Part II. Natural history of subarachnoid haemorrhage, intracranial aneurysm and arteriovenous malformations. J. Neurosurg.25 (1966), 321–368.

    PubMed  Google Scholar 

  • Merskey, C., Lalezari, P., Johnson, A. J., A rapid simple method for measuring fibrinolytic split products in human serum. Proc. Soc. Exp. Biol. Med.131 (1969), 871–875.

    PubMed  Google Scholar 

  • Mullan, S., Dawley, J., Antifibrinolytic therapy for intracranial aneurysms. J. Neurosurg.28 (1968), 21–23.

    PubMed  Google Scholar 

  • Naye, R. L., Thrombotic state after a haemorrhage diathesis, a possible complication of therapy with epsilon-aminocaproic acid. Blood19 (1962), 694–701.

    PubMed  Google Scholar 

  • Nibbelink, W. D., Cooperative aneurysm study. In: Cerebral Vascular Disorders, pp. 155–173 (Whisnant, J. P., Sandok, B. A., eds.). New York: Grune and Stratton. 1975.

    Google Scholar 

  • Nilsson, J. M., Andersson, L., Björkman, S. E., Epsilon-amino-caproic acid (EACA)as a therapeutic agent based on 5 years clinical experience. Acta Med. Scand. (Suppl.)448 (1966), 5–46.

    Google Scholar 

  • Norlén, G., Thulin, C. A., The use of antifibrinolytic substances in rupturedintracranial aneurysms. Neurochirurgia12 (1969), 100–102.

    PubMed  Google Scholar 

  • Rossum, J. v., Wintzen, A. R., Endtz, L. J., Schoen, J. H. R., Jonge, H. d., Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a doubleblind controlled clinical trial. Ann. Neurol.2 (1977), 242–245.

    Google Scholar 

  • Schisano, G., The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage. Surg. Neurol.10 (1978), 217–222.

    PubMed  Google Scholar 

  • Smith, R. R., Upchurch, J. J., Monitoring antifibrinolytic therapy in subarachnoid haemorrhage. J. Neurosurg.38 (1973), 339–343.

    PubMed  Google Scholar 

  • Sonntag, V. H. K., Stein, B. M., Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon aminocaproic acid. J. Neurosurg.40 (1974), 480–485.

    PubMed  Google Scholar 

  • Tovi, D., The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage. Acta Neurol. Scand.49 (1973), 163–175.

    PubMed  Google Scholar 

  • —, Thulin, C. A., Ability of tranexamic acid to cross the blood-brain barrier and its use in patients with ruptured intracranial aneurysm. Acta Neurol. Scand.48 (1972), 257–263.

    Google Scholar 

  • Tow, D. F., Wagner, H. N., Jr., North, W. A., Detection of venous obstruction in the legs with 99mTc-albumin. J. Nucl. Med.8 (1967), 277–281.

    Google Scholar 

  • Uttley, D., Richardson, A. E., EACA and subarachnoid hemorrhage. Lancet2 (1974), 1080–1081.

    Google Scholar 

Download references

Author information

Author notes

  1. H. J. Gelmers

    Present address: Department of Neurology, Pr. Irene Ziekenhuis, Almelo, The Netherlands

Authors and Affiliations

  1. Department of Neurosurgery, State University of Groningen, Almelo, The Netherlands

    H. J. Gelmers

Authors
  1. H. J. Gelmers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gelmers, H.J. Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid. Acta neurochir 52, 45–50 (1980). https://doi.org/10.1007/BF01400945

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01400945

Keywords

Search

Navigation